Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

22 mai 2017 08h01 HE | Source: Valeritas, Inc.

Valeritas’ V-Go® Wearable Insulin Delivery Device Results in Significant Reductions in A1C, Insulin Requirements and Cost Reductions in Patients with Diabetes

BRIDGEWATER, N.J., May 22, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced that clinical data demonstrating use of its V-Go® Wearable Insulin Delivery Device results...
12 mai 2017 08h05 HE | Source: Valeritas, Inc.

Valeritas Reports First Quarter 2017 Financial Results

BRIDGEWATER, N.J., May 12, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (Nasdaq:VLRX) today announced financial results for the first quarter ended March 31, 2017. First Quarter 2017 and...
08 mai 2017 08h01 HE | Source: Valeritas, Inc.

Valeritas to Present at the 18th Annual B. Riley Co. Investor Conference

BRIDGEWATER, N.J., May 08, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX) announced today that the Company is scheduled to present at the 18th Annual B. Riley Co. Investor...
04 mai 2017 16h01 HE | Source: Valeritas, Inc.

Valeritas’ V-Go® Wearable Insulin Delivery Device Provided Significant and Sustained A1C Reductions and Achieved A1C Glycemic Targets in Patients with Type 2 Diabetes

BRIDGEWATER, N.J., May 04, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced that clinical data demonstrating that use of the V-Go® Wearable Insulin Delivery Device...
03 mai 2017 08h01 HE | Source: Valeritas, Inc.

Valeritas to Host Conference Call with Clinical Experts to Discuss their Treatment of Patients with Type 2 Diabetes and V-Go® on May 18, 2017

BRIDGEWATER, N.J., May 03, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced that the Company will host a conference call with clinical experts to discuss their...
01 mai 2017 08h30 HE | Source: Valeritas, Inc.

Valeritas Announces Presentations for Upcoming Medical Conferences: AACE, ISPOR and ADA

BRIDGEWATER, N.J., May 01, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced that multiple abstracts supporting its wearable insulin delivery technology have been...
27 avr. 2017 08h30 HE | Source: Valeritas, Inc.

Valeritas to Release First Quarter 2017 Financial Results and Host Conference Call on Friday, May 12, 2017

BRIDGEWATER, N.J., April 27, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced that it will release its first quarter 2017 financial results on Friday, May 12, 2017...
30 mars 2017 08h30 HE | Source: Valeritas, Inc.

Article Published in Managed Care Highlights the Benefits of Diabetes Medication Delivery Devices, Including Valeritas’ V-Go® Device

BRIDGEWATER, N.J., March 30, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced the publication of an article that highlights the benefit of diabetes medication delivery...
23 mars 2017 07h00 HE | Source: Valeritas, Inc.

Valeritas Announces Pricing of $52.5 Million Public Offering of Common Stock

BRIDGEWATER, N.J., March 23, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (OTCQB:VLRX) today announced the pricing of its underwritten public offering of 5,250,000 shares of its common stock at...
13 mars 2017 16h00 HE | Source: Valeritas, Inc.

Valeritas Announces Reverse Stock Split

BRIDGEWATER, N.J., March 13, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (OTCQB:VLRX) today announced that effective at 9:00 a.m., EDT, on March 15, 2017, the Company will effect an...

Page précédente